Antimicrobial Resistance
On this page
Direct answer
The red line on an antibiotic strip is India's most visible answer to antimicrobial resistance: since 2016 the "Medicines with the Red Line" campaign has marked prescription-only antimicrobials so the public learns never to self-medicate them. Resistance is bacteria's natural selection accelerated by misuse — over-the-counter sale, short or wrong courses, hospital overuse and agricultural feeding — and its scale is alarming: the WHO lists AMR among the top ten threats to global health, and the landmark O'Neill review projected ten million deaths a year worldwide by 2050 if unchecked. India's structured response began with the Chennai Declaration (2012, a medical-societies roadmap), continued through Schedule H1 (2014, restricted-sale antibiotics), the National Action Plan on AMR (April 2017, aligned with the WHO's 2015 global plan on One Health lines) and the 2019 ban on colistin in animal feed, while surveillance runs through the ICMR network and WHO's GLASS.
What you must remember
- Milestones in order: Chennai Declaration 2012 → Schedule H1 (2014) → Red Line campaign (2016) → National Action Plan on AMR (2017, One Health framing) → colistin ban in poultry feed (2019) — a chronology question waiting to happen.
- NAP-AMR priorities: awareness and education, surveillance (ICMR's AMR surveillance network feeding GLASS), infection prevention and control, optimising antimicrobial use in health, animal and food sectors, research and development, and international collaboration.
- Schedule H1: a drug-rules category carrying the Rx symbol and a warning; pharmacists must record prescriptions in a separate register retained for three years — covers potent agents including third-generation cephalosporins, carbapenems and colistin.
- AWaRe classification (WHO): antibiotics sorted into Access, Watch and Reserve groups, with a WHO benchmark that at least 60 per cent of national consumption come from Access — a new-generation exam fact.
- Bug-weapon pairings: MRSA (methicillin-resistant Staphylococcus aureus), VRE (vancomycin-resistant enterococci), ESBL and carbapenemase-producing Enterobacteriaceae — including NDM-1, the New Delhi metallo-beta-lactamase first described in 2009 — and colistin resistance as the last-ditch failure.
- Estimates worth quoting: the O'Neill review's ten million annual deaths by 2050 and roughly 700,000 current resistant deaths globally; a large share of global antibiotic use is in animals, driving the feed ban.
- Stewardship package: prescription audits, hospital antibiotic policies, de-escalation on culture reports, hand hygiene (WHO's five moments), and infection control committees — the hospital's share of the fight.
- One Health: human, animal and environmental sectors jointly, because resistant genes travel through food, water and effluents — the WHO-FAO-WOAH-UNEP quadripartite coordination.
One prescription, audited
A junior doctor admits a febrile infant and reflexively starts a third-generation cephalosporin plus colistin "to cover everything". The antibiotic stewardship committee's audit later flags it: no cultures sent before the first dose, no de-escalation when the urine grew an ESBL-producing Klebsiella sensitive to a narrower agent, dual Gram-negative cover without justification. The stewardship response is structural, not scolding — a hospital antibiogram updated twice a year, a restricted-drug formulary requiring justification for Watch and Reserve group agents, a pharmacist reviewing culture reports at 48-72 hours, and hand-hygiene compliance rounds. Multiply the audit across a network of ICMR surveillance laboratories and the sample becomes national resistance trend data — the difference between one saved infant and a policy that saves a cohort.
Where students slip
Chronology mistakes dominate: the Chennai Declaration (2012) was a professional-societies roadmap, the National Action Plan (2017) was governmental — swapping their years or natures fails the stem. Second, Schedule H1 is about sale documentation (Rx symbol, separate register), while the red line is a public-awareness cue on the pack — the two get fused incorrectly. Third, AWaRe asks for groups, not drugs: memorise one example each (Access — amoxicillin; Watch — ceftriaxone; Reserve — colistin) to answer either direction. Fourth, NDM-1 is a carbapenemase (metallo-enzyme), and colistin is the salvage drug whose loss defines pan-resistance; the 2019 Indian ban concerned colistin in animal feed, not human use. Finally, attribute the ten-million figure to the O'Neill review, never to WHO.
Frequently asked questions
What was the Chennai Declaration of 2012?
A roadmap to tackle antimicrobial resistance adopted by Indian medical societies — proposing standard treatment guidelines, antibiotic policies and restricted over-the-counter sale, before the government plan followed.
What does the red line on an antibiotic packet signify?
The 2016 public campaign marking prescription-only antimicrobials, warning consumers against self-medication without a doctor's prescription.
What is the WHO AWaRe classification?
A three-group classification of antibiotics — Access, Watch and Reserve — guiding stewardship, with a WHO benchmark of at least 60 per cent Access-group use.
What is India's National Action Plan on AMR?
The 2017 government plan (aligned with the WHO Global Action Plan) built on One Health, spanning surveillance, infection control, awareness and regulation across human, animal and food sectors.
Why was colistin banned in poultry feed?
To preserve colistin as a last-resort human antibiotic by cutting its non-therapeutic use in food animals, a recognised amplifier of transferable colistin resistance.